FDA allows drugs without proven clinical benefit to languish for years on accelerated pathway Post date 30 July 2021 ← Covid-19: NICE issues guidance on vaccine induced immune thrombocytopenia and thrombosis → Subacute small bowel obstruction or chronic large bowel obstruction